„Psychopharmakotherapie“ (PPT) is the only German-language journal with a single focus on the pharmacotherapy of psychiatric and neurologic diseases, especially under the aspects pharmacology, evaluation in clinical studies, postmarketing surveillance, drug risks, pharmacoeconomics, and practical experiences . Its aim is to inform German-speaking psychiatrists and neurologists (clinicians as well as practitioners) on best practice and current developments in this field. PPT provides reviews, original (= research) papers, editorials, commentaries, case reports, and short reports on high-level publications and congress presentations. Reviews, original papers, commentaries, and case reports are subject to peer review.
